tive
vaccin
ebola
viru
infect
passiv
transfer
glycoprotein
gp
specif
antibodi
ab
prior
hour
viral
challeng
provid
protect
lethal
ebola
viru
infect
anim
model
transfer
sera
specif
gp
rather
viral
protein
confer
effect
protect
gp
epitop
studi
associ
abmedi
protect
case
survivor
ebola
viru
infect
earli
proinflammatori
respons
persist
increas
ebola
virusspecif
igg
level
detect
furthermor
monkey
treat
ab
cocktail
zmab
compos
three
differ
monoclon
ab
mab
mousehuman
chimer
specif
gp
within
hour
follow
lethal
challeng
ebola
viru
protect
death
anim
without
zmab
treatment
die
within
day
viral
infect
surviv
anim
rechalleng
lethal
ebola
viru
dose
maintain
activ
immun
statu
protect
viru
infect
collect
data
highlight
import
function
gpspecif
ab
control
ebola
viru
infect
electropor
ep
known
effect
dna
deliveri
method
induct
adapt
immun
respons
exampl
intramuscular
im
ep
epgener
electr
puls
induc
pore
format
cell
membran
muscl
cell
antigen
present
cell
apc
lead
effici
entri
express
dna
vaccin
cell
facilit
immun
induct
addit
stimul
caus
needl
inject
ep
attract
immun
cell
includ
apc
cell
dna
inject
site
lead
enhanc
induct
adapt
immun
respons
unlik
recombin
proteinbas
vaccin
moreov
dna
vaccin
thought
better
induc
ab
recogn
nativ
form
protein
antigen
dna
vaccin
express
encod
protein
target
cell
manner
similar
natur
viral
infect
context
like
imep
dna
vaccin
effici
elicit
ab
capabl
block
viral
infect
addit
purif
dna
vaccin
far
easier
purif
protein
knowledg
dna
vaccin
report
use
gener
hybridoma
thu
test
whether
dna
vaccin
could
use
hybridoma
product
studi
util
imep
deliveri
gp
dna
vaccin
gener
mab
gener
hybridoma
via
fusion
splenocyt
gp
dna
vaccineimmun
mice
myeloma
cell
among
hybridoma
display
reactiv
gp
enzymelink
immunosorb
assay
elisa
use
limit
dilut
subclon
obtain
monoclon
hybridoma
among
secret
igm
type
secret
igg
type
particular
purifi
igm
ab
igg
fail
recogn
gp
elisa
howev
boost
protein
antigen
gp
facilit
effici
gener
iggsecret
hybridoma
gp
dna
vaccin
alon
data
suggest
immun
gp
dna
vaccin
lead
preferenti
product
hybridoma
secret
igm
ab
littl
antigen
specif
boost
gp
overcom
propens
taken
togeth
data
suggest
boost
gp
could
use
produc
hybridoma
secret
antigenspecif
igg
ab
sixweekold
femal
balbc
mice
purchas
daehan
biolink
eumseong
korea
nude
mice
balbc
origin
purchas
orientbio
seongnam
korea
mice
care
guidelin
kangwon
institut
anim
care
use
committeeapprov
protocol
cell
purchas
korean
cell
line
bank
seoul
korea
cell
maintain
cdmem
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
lglutamin
penicillinstreptomycin
ebola
viru
zair
ebola
viru
strain
gp
gene
bp
genebank
codonoptim
synthes
genscript
hong
kong
synthes
gp
dna
sequenc
clone
backbon
vector
invitrogen
carlsbad
ca
usa
design
recombin
gp
gener
cell
purchas
ybiolog
daejeon
korea
product
dna
sequenc
encod
region
gener
use
primer
set
tabl
dna
fragment
digest
ecori
xhoi
gelpurifi
dna
fragment
clone
ecori
xhoi
site
pet
vector
novagen
madison
wi
usa
plasmid
construct
transform
escherichia
coli
cell
select
kanamycin
http
wwwecevrorg
http
vector
purifi
transform
cell
incub
luriabertani
broth
supplement
kanamycin
final
concentr
cell
incub
shaker
absorb
nm
absorb
unit
protein
induc
addit
mm
isopro
hour
cell
pellet
collect
minut
subject
singl
freezethaw
cycl
cell
pellet
resuspend
ml
urea
buffer
ph
per
gram
wet
weight
cell
lyse
stir
minut
room
temperatur
centrifug
minut
cell
supernat
collect
pass
ninta
resin
column
qiagen
valencia
ca
usa
preequilibr
urea
buffer
ph
resin
wash
ed
volum
buffer
b
urea
buffer
ph
volum
buffer
c
urea
buffer
ph
final
step
histag
elut
ml
buffer
c
contain
mm
imidazol
protein
solut
dialyz
urea
buffer
follow
urea
buffer
interv
follow
overnight
dialysi
phosphatebuff
salin
pb
protein
concentr
determin
use
bicinchonin
acid
protein
assay
kit
thermo
scientif
rockford
il
usa
imep
deliveri
dna
vaccin
mice
inject
intramuscularli
per
mous
final
volum
pb
use
needl
inject
follow
ep
v
second
use
cellectra
system
vgx
intern
incinovio
accord
manufactur
protocol
plasmid
dna
produc
bacteria
purifi
use
endotoxinfre
qiagen
kit
accord
manufactur
protocol
qiagen
deliveri
gp
mice
inject
intraven
gp
per
mous
final
volum
pb
mice
sacrif
indic
time
point
follow
last
inject
splenocyt
prepar
fusion
fusion
perform
previous
describ
brief
splenocyt
cell
fuse
cell
use
polyethylen
glycol
peg
cell
incub
day
cdmem
contain
hypoxanthineaminopterinthymidin
hat
cell
incub
cdmem
contain
hypoxanthinethymidin
ht
day
cell
supernat
screen
detect
presenc
absecret
hybridoma
use
elisa
product
mab
absecret
hybridoma
dilut
less
singl
cell
per
well
use
limit
dilut
subclon
method
peg
hat
ht
purchas
sigmaaldrich
st
loui
mo
hybridoma
cell
cultur
cdmem
contain
ht
cell
supernat
collect
use
purif
mab
altern
ascit
fluid
gener
inject
hybridoma
cell
intraperiton
nude
mice
nude
mice
inject
intraperiton
pristan
week
prior
hybridoma
cell
inject
nude
mice
lack
cell
chosen
tend
form
ascit
fluid
easili
balbc
mice
mice
becam
notic
larg
collect
ascit
fluid
needl
attach
syring
incub
fluid
hour
overnight
centrifug
minut
remov
oil
layer
cell
pellet
collect
fluid
supernat
use
purif
mab
mab
igg
purifi
use
protein
g
resin
column
accord
manufactur
protocol
peptron
daejeon
korea
briefli
protein
g
resin
column
preequilibr
ml
bind
buffer
sodium
phosphat
buffer
nacl
ph
sampl
filter
filter
mix
equal
volum
bind
buffer
mix
sampl
load
onto
resin
column
wash
twice
ml
bind
buffer
final
bound
ab
elut
ad
elut
buffer
glycin
buffer
ph
particular
ad
neutral
buffer
tri
hcl
buffer
ph
ml
elut
sampl
fraction
adjust
ph
util
differ
method
purifi
igm
first
method
igm
purifi
use
hitrap
igm
purif
column
accord
manufactur
protocol
ge
healthcar
cleveland
oh
usa
brief
column
preequilibr
ml
bind
buffer
mm
sodium
phosphat
ph
sampl
pass
filter
mix
equal
volum
bind
buffer
mix
sampl
load
ed
onto
column
follow
wash
ml
bind
buffer
bound
igm
elut
ad
elut
buffer
mm
sodium
phosphat
ph
second
method
igm
purifi
use
protein
l
resin
column
accord
manufactur
protocol
amicogen
jinju
korea
briefli
protein
l
resin
column
preequilibr
ml
bind
buffer
sodium
phosphat
buffer
nacl
ph
sampl
pass
filter
mix
equal
volum
bind
buffer
mix
sampl
load
onto
resin
column
wash
twice
ml
bind
buffer
final
bound
ab
elut
ad
elut
buffer
glycin
buffer
ph
particular
ad
neutral
buffer
trishcl
buffer
ph
ml
elut
sampl
fraction
adjust
ph
final
ab
dialyz
pb
well
well
plate
coat
overnight
recombin
gp
pb
next
day
plate
wash
time
wash
buffer
tween
block
hour
block
buffer
wash
buffer
bovin
serum
albumin
plate
react
hour
horseradish
peroxidas
hrp
conjug
antimous
igg
hl
hrpconjug
antimous
igm
hrpconjug
antimous
iga
hrpconjug
antimous
igg
fcspecif
dilut
block
buffer
wash
plate
abt
solut
merck
millipor
billerica
usa
ad
well
optic
densiti
read
nm
use
elisa
reader
determin
rel
level
gpspecif
igg
subclass
substitut
hrpconjug
antimurin
ab
thermo
scientif
hrpconjug
antimurin
igg
hl
hrpconjug
antimous
igg
hl
hrpconjug
antimous
igm
purchas
komabiotech
seoul
korea
hrpconjug
antimous
igg
fcspecif
hrpconjug
antimous
iga
purchas
sigmaaldrich
thermo
scientif
respect
protein
sampl
separ
sodium
dodecyl
sulfat
sd
polyacrylamid
gel
protein
gel
analyz
stain
brilliant
blue
stain
solut
elpisbiotech
daejeon
korea
protein
also
electrophoret
transfer
immobilonp
membran
merck
millipor
membran
preequilibr
tbst
solut
mm
trishcl
ph
mm
nacl
tween
contain
skim
milk
hour
detect
ab
membran
incub
hrpconjug
antimous
igg
hl
komabiotech
hour
room
temperatur
step
membran
wash
time
tbst
immunoreact
protein
band
visual
use
ecl
detect
reagent
philekorea
seoul
korea
statist
analysi
perform
independ
test
use
spss
ver
spss
inc
chicago
il
usa
valu
experiment
group
compar
valu
control
group
pvalu
consid
signific
first
construct
dna
vaccin
code
ebola
viru
gp
use
codonoptim
ebola
viru
gp
dna
sequenc
design
fig
test
whether
gp
dna
vaccin
could
induc
antigenspecif
ab
respons
mice
immun
imep
week
bled
week
fig
fig
show
elisa
data
gp
dna
vaccin
gp
dna
vaccin
induc
significantli
greater
antigenspecif
ab
respons
control
vector
recombin
gp
kda
use
coat
antigen
elisa
fig
result
suggest
gp
dna
vaccin
elicit
antigenspecif
ab
respons
vivo
obtain
splenocyt
fusion
mice
inject
imep
gp
dna
vaccin
one
week
last
inject
mice
sacrif
splenocyt
use
http
wwwecevrorg
http
fusion
fig
assay
gener
hybridoma
among
five
found
secret
ab
reactiv
gp
elisa
use
hrpconjug
antimous
igg
hl
secondari
ab
util
hybridoma
cell
supernat
select
hybridoma
secret
gpspecif
ab
five
hybridoma
design
also
gener
hybridoma
mice
sacrif
week
last
inject
fig
among
four
found
elisa
secret
ab
reactiv
gp
four
hybridoma
design
addit
produc
hybridoma
mice
sacrif
week
last
inject
fig
among
four
found
elisa
secret
ab
reactiv
gp
four
hybridoma
design
mab
product
hybridoma
dilut
gener
singl
cell
clone
use
limit
dilut
subclon
method
result
monoclon
hybridoma
clone
obtain
howev
clone
becam
contamin
thu
clone
select
design
next
test
elisa
cell
supernat
clone
contain
mab
could
bind
gp
seen
fig
clone
display
reactiv
gp
elisa
use
hrpconjug
antiigg
hl
secondari
ab
howev
clone
fail
react
gp
elisa
use
hrpconjug
antiigm
secondari
ab
fig
display
reactiv
antiigm
moreov
none
clone
show
reactiv
gp
elisa
use
hrpconjug
antiiga
secondari
ab
fig
cell
supernat
clone
show
reactiv
gp
elisa
use
hrpconjug
antiigg
fcspecif
secondari
ab
fig
data
suggest
clone
may
produc
antigenspecif
igm
except
clone
appear
secret
antigenspecif
igg
confirm
find
cell
supernat
clone
test
western
blot
assay
use
hrpconjug
antiigg
hl
seen
fig
sampl
clone
show
presenc
igg
h
kda
l
kda
chain
wherea
remain
clone
display
l
chain
result
suggest
clone
secret
antigenspecif
igm
clone
secret
antigenspecif
igg
taken
togeth
result
indic
igmsecret
hybridoma
predominantli
gener
immun
dna
vaccin
code
ebola
viru
gp
product
ebola
viru
assess
capac
mab
recogn
whole
ebola
viru
gp
includ
signal
peptid
put
receptorbind
domain
mucinlik
region
transmembran
region
shown
fig
gener
four
recombin
construct
span
receptorbind
domain
one
recombin
span
mucinlik
region
amino
acid
sequenc
number
five
recombin
construct
also
shown
fig
recombin
molecul
gener
use
e
coli
system
purifi
ran
sdspolyacrylamid
gel
kda
protein
plu
histag
kda
protein
plu
histag
kda
protein
plu
histag
kda
protein
plu
histag
kda
protein
plu
histag
respect
fig
particular
molecular
mass
kda
larger
predict
concentr
calcul
mgml
respect
next
evalu
reactiv
cell
supernat
clone
elisa
use
hrpconjug
antiigg
hl
secondari
ab
shown
fig
cell
supernat
clone
display
higher
though
variabl
bind
reactiv
neg
control
contrast
cell
supernat
clone
display
bind
activ
littl
data
suggest
hybridoma
clone
may
secret
igm
ab
high
avid
mul
igg
purifi
cell
supernat
use
protein
gresin
column
igm
purifi
either
ascit
fluid
use
hitrap
igm
purif
kit
cell
supernat
use
protein
l
resin
column
purifi
ab
run
sodium
dodecyl
sulfatepolyacrylamid
gel
brilliant
blue
stain
purifi
igg
igm
ab
react
enzymelink
immunosorb
assay
use
hrpconjug
antiigg
hl
secondari
antibodi
posit
control
gpspecif
sera
dilut
fig
wherea
neg
control
naiv
sera
dilut
od
optic
densiti
tipl
antigen
therefor
purifi
mab
cell
supernat
ascit
fluid
clone
use
protein
g
resin
column
purifi
igg
cell
supernat
clone
igm
purifi
either
ascit
fluid
clone
use
hitrap
igm
purif
kit
cell
supernat
clone
use
protein
l
resin
column
base
avail
hitrap
igm
purif
kit
l
resin
column
purifi
igg
clone
display
h
l
chain
sdspolyacrylamid
gel
wherea
purifi
igm
ab
display
h
l
chain
fig
next
test
abil
purifi
igg
igm
ab
recogn
elisa
igg
clone
react
fig
contrast
none
purifi
igm
ab
recogn
either
taken
togeth
data
show
igg
clone
recogn
peptid
sequenc
ebola
viru
mucinlik
region
howev
igm
ab
clone
fail
recogn
ebola
viru
suggest
igm
ab
antigenspecif
igg
clone
test
determin
igg
subclass
found
type
fig
moreov
lowest
concentr
igg
clone
display
gp
reactiv
determin
ngml
fig
compar
effect
deliveri
method
sourc
gp
product
igmand
iggsecret
hybridoma
igg
clone
serial
dilut
react
parallel
control
igg
determin
lowest
concentr
gp
bind
use
elisa
od
optic
densiti
boosterinject
mice
gp
dna
vaccin
imep
gp
intraven
deliveri
gp
intraven
deliv
solubl
protein
final
boost
intraven
deliveri
recommend
method
solubl
protein
antigen
boosterinject
mice
gp
dna
vaccin
six
hybridoma
select
elisa
fig
select
hybridoma
secret
igm
isotyp
measur
elisa
use
hrpantiigg
hl
hrpantiigm
secondari
ab
fig
cell
supernat
six
hybridoma
test
presenc
igm
western
blot
assay
use
hrpconjug
antiigg
hl
display
l
chain
fig
confirm
six
hybridoma
produc
igm
isotyp
ab
contrast
control
igg
clone
display
h
l
chain
data
corrobor
notion
dna
vaccin
lead
preferenti
product
igmsecret
hybridoma
mice
receiv
booster
inject
gp
produc
hybridoma
fig
particular
three
hybridoma
secret
igm
isotyp
wherea
nine
hybridoma
secret
igg
isotyp
ab
determin
elisa
use
hrpconjug
antiigg
hl
hrpconjug
igm
secondari
ab
confirm
western
blot
assay
fig
igg
type
wherea
two
hybridoma
produc
igm
type
howev
cell
supernat
remain
hybridoma
exhibit
neither
igmspecif
reactiv
gp
elisa
kda
h
chain
western
blot
assay
suggest
hybridoma
might
produc
ab
igg
igm
case
hybridoma
cell
supernat
exhibit
igmspecif
reactiv
gp
elisa
h
chain
western
blot
assay
suggest
hybridoma
might
polyclon
produc
igg
igm
taken
togeth
collect
data
show
protein
boost
follow
dna
vaccin
might
revers
hybridoma
product
profil
igmto
iggsecret
hybridoma
studi
observ
igmsecret
hybridoma
preferenti
produc
immun
dna
vaccin
encod
ebola
viru
gp
cell
supernat
igmspecif
hybridoma
clone
display
bind
activ
differ
part
gp
elisa
suggest
igmspecif
hybridoma
cell
might
gener
igm
ab
littl
antigen
specif
despit
howev
purifi
igm
ab
unabl
recogn
gp
present
unclear
unlik
hybridoma
cell
supernat
purifi
igm
ab
exhibit
bind
gp
phenomenon
also
observ
anim
immun
dna
vaccin
code
surfac
antigen
infecti
virus
includ
middl
east
respiratori
syndromecaus
coronavirus
sever
fever
thrombocytopenia
syndrom
virus
data
includ
hand
purifi
monoclon
igg
one
hybridoma
clone
type
bind
activ
mucinlik
region
gp
addit
preferenti
product
igmsecret
hybridoma
observ
anim
boosterinject
foot
pad
gp
dna
vaccin
intraven
tuhttp
wwwecevrorg
http
mor
cell
express
gp
data
shown
unexpect
observ
studi
ab
produc
serum
anim
immun
gp
dna
vaccin
order
igm
quantiti
data
includ
result
impli
dna
vaccin
abl
induc
product
igg
ab
anim
switch
igm
igg
b
cell
context
like
preferenti
product
igmsecret
hybridoma
iggsecret
hybridoma
dna
vaccin
might
ascrib
lack
b
cell
switch
igg
isotyp
instead
natur
dna
vaccin
nonspecif
immun
induc
might
attribut
product
hybridoma
secret
igm
ab
littl
antigen
specif
idea
support
previou
find
unmethyl
cpg
motif
bacteriaderiv
dna
respons
nonspecif
immun
stimul
polyclon
b
cell
activ
also
observ
use
gp
boost
follow
dna
vaccin
deliveri
led
preferenti
product
iggsecret
hybridoma
igmsecret
hybridoma
observ
nearli
hybridoma
gener
boost
gp
dna
vaccin
produc
igm
type
wherea
hybridoma
gener
boost
gp
produc
igm
type
furthermor
hybridoma
obtain
boost
gp
nine
produc
igg
isotyp
ab
cell
supernat
suggest
import
role
protein
boost
preferenti
product
iggsecret
hybridoma
cell
supernat
contain
mostli
lesser
degre
isotyp
data
shown
impli
igg
respons
might
prime
dna
vaccin
previous
report
contrari
dna
vaccin
protein
vaccin
abl
induc
littl
antigenspecif
product
find
along
previou
find
suggest
antigenspecif
ab
respons
prime
dna
vaccin
may
boost
protein
immun
lead
preferenti
product
iggsecret
hybridoma
notion
support
fact
b
cell
use
target
fusion
hybridoma
product
day
protein
booster
inject
unlik
experienc
class
switch
igm
igg
need
product
iggsecret
hybridoma
inde
observ
signific
level
antigenspecif
igm
igg
detect
sera
obtain
day
inject
recombin
gp
absenc
prime
dna
vaccin
data
shown
idea
also
support
previou
find
protein
primingprotein
boost
effect
isotyp
induct
wherea
dna
primingprotein
boost
dramat
increas
product
thu
recombin
protein
final
booster
vaccin
may
play
role
increas
product
iggsecret
hybridoma
dna
vaccin
platform
taken
togeth
data
suggest
protein
boost
follow
dna
vaccin
might
use
gener
iggsecret
hybridoma
present
studi
also
observ
purifi
monoclon
igg
ab
resolv
two
protein
band
h
chain
l
chain
sdspolyacrylamid
gel
purifi
monoclon
igm
ab
differ
size
band
h
chain
l
chain
addit
h
l
chain
igg
l
chain
igm
recogn
hrpconjug
antiigg
hl
western
blot
assay
consist
elisa
data
show
igg
igm
recogn
hrpconjug
antiigg
hl
igm
recogn
hrpconjug
antiigm
thu
result
show
hrpconjug
antiigg
hl
util
secondari
ab
measur
level
igm
plu
igg
isotyp
gp
respons
bind
host
cell
receptor
viral
entri
observ
purifi
monoclon
igg
clone
recogn
mucinlik
region
gp
would
also
interest
test
part
gp
recogn
igg
ab
purifi
nine
iggsecret
hybridoma
ab
particular
igg
ab
gp
bind
activ
could
act
neutral
ab
block
hostviru
interact
util
treat
patient
ebola
viru
infect
reactiv
addit
igg
ab
test
vitro
anim
studi
summari
dna
vaccin
preferenti
produc
igmsecret
hybridoma
iggsecret
hybridoma
howev
boost
recombin
protein
follow
dna
immun
facilit
product
higher
proport
iggsecret
hybridoma
thu
protein
boost
approach
may
implic
product
iggspecif
hybridoma
dna
vaccin
platform
